Lucid Diagnostics (LUCD) Assets Average (2021 - 2026)
Lucid Diagnostics' (LUCD) quarterly Assets Average came in at $37.3 million in Q1 2026, up 17.34% YoY from $31.8 million in Q1 2025, and down 20.42% on a QoQ basis from $46.8 million in Q4 2025.
Lucid Diagnostics (LUCD) Assets Average (2021 - 2026) Analysis & Trends
Lucid Diagnostics (LUCD) has 6 years of Assets Average data on file, last reported at $37.3 million in Q1 2026.
- Quarterly Assets Average rose 17.34% year-over-year to $37.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $37.3 million (up 17.34% YoY) and the FY2025 annual result came in at $35.6 million, up 22.72% from the prior year.
- Assets Average retreated to $37.3 million in Q1 2026, from $46.8 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $60.5 million in Q1 2022 to a low of $26.7 million in Q4 2024.
- A 5-year average of $38.9 million and a median of $37.3 million in 2026 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2023 — Assets Average plunged 32.57% — and 2025, when it jumped 75.65%.
- Tracing LUCD's Assets Average over 5 years: stood at $35.4 million in 2022, then fell by 14.63% to $30.3 million in 2023, then declined by 11.9% to $26.7 million in 2024, then jumped by 75.65% to $46.8 million in 2025, then declined by 20.42% to $37.3 million in 2026.
- The last three Assets Average figures came in at $37.3 million (Q1 2026), $46.8 million (Q4 2025), and $45.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 109.82 Bn |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 47.11 Bn |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 92.26 Bn |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 44.78 Bn |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 13.59 Bn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 6.54 Bn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 37.19 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 31.48 Bn |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Lucid Diagnostics | 176.81 Mn | 143.40 Mn | 55,000.00 | 36.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 36.51 Mn |
| Mar 31, 2026 | 37.26 Mn |
| Dec 31, 2025 | 46.82 Mn |
| Sep 30, 2025 | 45.93 Mn |
| Jun 30, 2025 | 35.73 Mn |
| Mar 31, 2025 | 31.76 Mn |
| Dec 31, 2024 | 26.66 Mn |
| Sep 30, 2024 | 28.36 Mn |
| Jun 30, 2024 | 33.08 Mn |
| Mar 31, 2024 | 29.66 Mn |
| Dec 31, 2023 | 30.26 Mn |
| Sep 30, 2023 | 37.87 Mn |
| Jun 30, 2023 | 45.81 Mn |
| Mar 31, 2023 | 40.82 Mn |
| Dec 31, 2022 | 35.44 Mn |
| Sep 30, 2022 | 41.89 Mn |
| Jun 30, 2022 | 53.73 Mn |
| Mar 31, 2022 | 60.53 Mn |
| Dec 31, 2021 | 31.15 Mn |